Pure Platelet and Leukocyte–Platelet-Rich Plasma for Regenerative Medicine in Orthopedics—Time- and Preparation-Dependent Release of Growth Factors and Effects on Synovial Fibroblasts: A Comparative Analysis
暂无分享,去创建一个
E. Mariani | C. R. Arciola | L. Pulsatelli | G. Filardo | L. Cattini | A. Di Martino | P. Dolzani | A. Cenacchi | E. Assirelli | C. Arciola
[1] G. Ruthel,et al. A Platelet-Rich Plasma-Derived Biologic Clears Staphylococcus aureus Biofilms While Mitigating Cartilage Degeneration and Joint Inflammation in a Clinically Relevant Large Animal Infectious Arthritis Model , 2022, Frontiers in Cellular and Infection Microbiology.
[2] M. Azkargorta,et al. Proteomic Characterization of Plasma Rich in Growth Factors and Undiluted Autologous Serum , 2021, International Journal of Molecular Sciences.
[3] Li-Hong Peng,et al. Molecular Mechanisms of Chondrocyte Proliferation and Differentiation , 2021, Frontiers in Cell and Developmental Biology.
[4] R. Takatori,et al. The Potential Role of Hepatocyte Growth Factor in Degenerative Disorders of the Synovial Joint and Spine , 2020, International journal of molecular sciences.
[5] Ángel García,et al. Deciphering the secretome of leukocyte-platelet rich fibrin: towards a better understanding of its wound healing properties , 2020, Scientific Reports.
[6] J. Eschweiler,et al. Comparison between intra-articular infiltrations of placebo, steroids, hyaluronic and PRP for knee osteoarthritis: a Bayesian network meta-analysis , 2020, Archives of Orthopaedic and Trauma Surgery.
[7] E. Mariani,et al. Platelet Concentrates in Musculoskeletal Medicine , 2020, International journal of molecular sciences.
[8] Yong-Beom Park,et al. Variability of the Composition of Growth Factors and Cytokines in Platelet-Rich Plasma From the Knee With Osteoarthritis. , 2019, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.
[9] J H Abbott,et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. , 2019, Osteoarthritis and cartilage.
[10] Alfred C. Gellhorn,et al. Platelet-Rich Plasma Use in Musculoskeletal Disorders: Are the Factors Important in Standardization Well Understood? , 2019, Physical medicine and rehabilitation clinics of North America.
[11] Nicholas M. Wragg,et al. The use of PRP injections in the management of knee osteoarthritis , 2019, Cell and Tissue Research.
[12] Zhongli Li,et al. Comparative study of different anticoagulants and coagulants in the evaluation of clinical application of platelet-rich plasma (PRP) standardization , 2019, Cell and Tissue Banking.
[13] P. Nurden,et al. Autologous fibrin scaffolds: When platelet- and plasma-derived biomolecules meet fibrin. , 2019, Biomaterials.
[14] J. Dragoo,et al. Current Clinical Recommendations for Use of Platelet-Rich Plasma , 2018, Current Reviews in Musculoskeletal Medicine.
[15] P. Kubes,et al. Start a fire, kill the bug: The role of platelets in inflammation and infection , 2018, Innate immunity.
[16] M. Quirynen,et al. Leucocyte- and platelet-rich fibrin (L-PRF) as a regenerative medicine strategy for the treatment of refractory leg ulcers: a prospective cohort study , 2018, Platelets.
[17] José F. Alfonso Sánchez,et al. Plasma rich in growth factors membrane as coadjuvant treatment in the surgery of ocular surface disorders , 2018, Medicine.
[18] D. Lansdown,et al. Platelet-Rich Plasma: Formulations, Preparations, Constituents, and Their Effects , 2017 .
[19] M. Marcacci,et al. Platelet-Rich Plasma: The Choice of Activation Method Affects the Release of Bioactive Molecules , 2016, BioMed research international.
[20] M. Marcacci,et al. Leukocyte presence does not increase microbicidal activity of Platelet-rich Plasma in vitro , 2015, BMC Microbiology.
[21] M. Marcacci,et al. Effect of two different preparations of platelet-rich plasma on synoviocytes , 2014, Knee Surgery, Sports Traumatology, Arthroscopy.
[22] V. Shetty,et al. Orthobiologics and platelet rich plasma , 2014, Indian journal of orthopaedics.
[23] N. Maffulli,et al. Platelet-rich plasma for managing pain and inflammation in osteoarthritis , 2013, Nature Reviews Rheumatology.
[24] M. Marcacci,et al. Preparation method and growth factor content of platelet concentrate influence the osteogenic differentiation of bone marrow stromal cells. , 2013, Cytotherapy.
[25] D. Zanetta-Barbosa,et al. Evaluation of the bone healing process utilizing platelet-rich plasma activated by thrombin and calcium chloride: a histologic study in rabbit calvaria. , 2013, The Journal of oral implantology.
[26] P. Boileau,et al. Leukocyte- and platelet-rich fibrin (L-PRF) for long-term delivery of growth factor in rotator cuff repair: review, preliminary results and future directions. , 2012, Current pharmaceutical biotechnology.
[27] Vasili Karas,et al. Platelet-rich plasma: a milieu of bioactive factors. , 2012, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.
[28] J. Dragoo,et al. Comparison of Growth Factor and Platelet Concentration From Commercial Platelet-Rich Plasma Separation Systems , 2011, The American journal of sports medicine.
[29] M. Egerbacher,et al. Platelet-rich fibrin constructs elute higher concentrations of transforming growth factor-β1 and increase tendon cell proliferation over time when compared to blood clots: a comparative in vitro analysis. , 2010, Veterinary surgery : VS.
[30] Ye Lin,et al. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. , 2009, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[31] L. Fortier,et al. Temporal growth factor release from platelet‐rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[32] R. Guaschino,et al. Not every PRP‐gel is born equal Evaluation of growth factor availability for tissues through four PRP‐gel preparations: Fibrinet®, RegenPRP‐Kit®, Plateltex® and one manual procedure , 2009, Vox sanguinis.
[33] G. Lippi,et al. Circadian variation within hemostasis: an underrecognized link between biology and disease? , 2009, Seminars in thrombosis and hemostasis.
[34] D. M. Dohan Ehrenfest,et al. Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies , 2009, Growth factors.
[35] T. Deliberador,et al. Bone healing in critical-size defects treated with platelet-rich plasma activated by two different methods. A histologic and histometric study in rat calvaria. , 2008, Journal of periodontal research.
[36] G. Orive,et al. Five-year clinical evaluation of short dental implants placed in posterior areas: a retrospective study. , 2008, Journal of periodontology.
[37] E. Mariani,et al. Simultaneous evaluation of circulating chemokine and cytokine profiles in elderly subjects by multiplex technology: relationship with zinc status , 2006, Biogerontology.
[38] Helen H. Lu,et al. Activation of platelet-rich plasma using thrombin receptor agonist peptide. , 2005, Journal of oral and maxillofacial surgery.
[39] Helen H. Lu,et al. Differential growth factor retention by platelet-rich plasma composites. , 2004, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[40] G. Hafner,et al. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. , 2002, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.